Table 1.
Common overexpressed genes in bovine CCs around the GVBD between FSH in vitro versus LH in vivo
| No. | Gene name | Gene/protein full name (if available) | Accession no. |
|---|---|---|---|
| 1 |
ATP1B4 |
Bos taurus ATPase, (Na+)/K + transporting, beta 4 polypeptide |
NM_001101919 |
| 2 |
ATP6V1C1 |
Bos taurus ATPase, H + transporting, lysosomal 42kDa, V1 subunit C1 |
NM_176676 |
| 3 |
BAMBI |
Bos taurus BMP and activin membrane-bound inhibitor homolog |
NM_001046309 |
| 4 |
HSPA8 |
Bos taurus heat shock 70 kDa protein 8 |
NM_174345 |
| 5 |
INHBA* |
Bos taurus inhibin, beta A |
NM_174363 |
| 6 |
PAPD1 |
Bos taurus PAP associated domain containing 1 |
BC104501 |
| 7 |
PSMA2 |
Bos taurus proteasome (prosome, macropain) subunit, alpha type, 2 |
BC102206 |
| 8 |
RHOA |
Bos taurus ras homolog gene family, member A |
NM_176645 |
| 9 |
RPL3 |
Bos taurus ribosomal protein L3 |
BT021012 |
| 10 |
SELK |
Bos taurus similar to selenoprotein K |
BC108150 |
| 11 |
SLC25A5 |
Bos taurus solute carrier family 25 member 5 |
BC102950 |
| 12 |
TNFAIP6* |
Bos taurus tumor necrosis factor, alpha-induced protein 6 |
NM_001007813 |
| 13 |
UBA6 |
Bos taurus ubiquitin-like modifier activating enzyme 6 |
NM_001083438 |
| 14 |
CHSY1 |
Homo sapiens carbohydrate (chondroitin) synthase 1 |
NM_014918 |
| 15 |
EREG● |
Homo sapiens epiregulin |
NM_001432 |
| 16 |
FOXO3A |
Homo sapiens forkhead box O3 (FOXO3), transcript variant 2, mRNA |
NM_201559 |
| 17 |
PGR* |
Bos taurus progesterone receptor |
NC_007313.4 |
| 18 |
NEAT1 |
Homo sapiens nuclear enriched abundant transcript 1 |
EF177379 |
| 19 |
SGMS2 |
Homo sapiens sphingomyelin synthase 2 (SGMS2), transcript variant |
NM_001136258 |
| 20 |
AGPAT9 |
PREDICTED: Bos taurus similar to 1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9 |
XM_597964 |
| 21 |
RBMX |
PREDICTED: Bos taurus similar to Heterogeneous nuclear ribonucleoprotein G |
XM_875611 |
| 22 | SLC39A8 | PREDICTED: Bos taurus similar to Solute carrier family 39 (zinc transporter), member 8 | XM_584935 |
Real-time PCR validation of overexpression following FSH in vitro(*) or LH in vivo (●); α = 0.05%.